睡眠障礙市場機會、成長促進因素、產業趨勢分析與預測 2025 - 2034

全球睡眠障礙市場預計2024 年價值276 億美元，預計2025 年至2034 年將以10.1% 的複合年成長率強勁成長。的需求不斷成長推動的。

受失眠、睡眠呼吸中止症和發作性睡病等睡眠障礙影響的人數不斷增加，是推動市場的關鍵因素之一。現代生活方式的特點是壓力更大、睡眠模式不規則和過度使用數位設備，這些都導致​​了睡眠相關問題的激增。隨著越來越多的人遇到睡眠困難，對藥物、治療設備和先進診斷工具等各種治療的需求不斷增加。

此外，人們對睡眠對整體健康重要性的認知不斷加深，也增強了大眾的意識。睡眠不佳與各種慢性健康問題有關，包括心血管疾病、肥胖和心理健康問題，促使更多人尋求解決方案。健康運動和教育措施正在傳播有關解決睡眠障礙重要性的訊息，從而刺激了對診斷服務和治療方案（包括療法和設備）的需求。

此市場按疾病類型分類，包括睡眠呼吸中止症、不寧腿症候群 (RLS)、失眠、發作性睡病等。睡眠呼吸中止症是最大的貢獻者，佔據了市場的很大一部分。這種疾病，特別是其阻塞性形式，非常普遍，尤其是在老年族群和具有其他危險因子的個體中。隨著人們對睡眠呼吸中止症的認知不斷提高，對診斷和治療解決方案的需求激增，進一步鞏固了該領域的市場主導地位。

治療領域預計將推動顯著成長，預計複合年成長率為10.5%，到2034 年將達到472 億美元以上。了關鍵作用。 CPAP 機等提供恆定氣流以保持呼吸道暢通的設備已得到改進，以提高舒適度和易用性。睡眠障礙治療保險的廣泛採用也使得治療變得更加容易，鼓勵更多的人尋求治療。

就最終用途而言，市場分為家庭護理場所和睡眠實驗室。在日益成長的自我管理趨勢的支持下，家庭照護環境佔據了市場主導地位。創新的家用診斷和治療設備，例如穿戴式睡眠追蹤器和攜帶式 CPAP 機，使個人能夠更輕鬆地在舒適的家中監測和治療睡眠障礙。

北美在睡眠障礙市場中佔有很大佔有率，到 2024 年價值將達到 106 億美元。公眾意識、保險覆蓋範圍和人口老化進一步鞏固了北美在全球市場的地位。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 睡眠障礙的盛行率不斷上升
    • 對攜帶式、高效、優質的睡眠障礙設備的需求不斷成長
    • 提高對睡眠障礙的認知
    • 睡眠科技設備的技術進步
  • 產業陷阱與挑戰
    • 嚴格的監管框架
• 成長潛力分析
• 技術景觀
• 未來市場趨勢
• 監管環境
• 報銷場景
• 差距分析
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按疾病類型，2021 - 2034 年

• 主要趨勢
• 睡眠呼吸中止症
  • 阻塞性睡眠呼吸中止症
  • 中樞性睡眠呼吸中止/複雜性睡眠呼吸暫停
  • 複雜的睡眠呼吸中止症
• 不寧腿症候群（RLS）
• 失眠
• 發作性睡病
• 其他疾病

第 6 章：市場估計與預測：按產品分類，2021 - 2034 年

• 主要趨勢
• 診斷
  • 多導睡眠圖 (PSG) 裝置
    • 流動 PSG 設備
    • 臨床 PSG 設備
  • 居家睡眠測試 (HST) 設備
    • 2型
    • 3型
    • 4型
  • 體動記錄系統
  • 睡眠篩檢設備
  • 脈搏血氧儀
  • 呼吸測謊儀
  • 穿戴式裝置
    • 智慧手錶和手環
    • 其他穿戴式裝置
• 療法
  • 認知行為療法
  • 治療設備
    • 氣道正壓通氣 (PAP) 裝置
      • 持續性呼吸道正壓通氣 (CPAP) 設備
      • 雙水平氣道正壓通氣 (BiPAP) 裝置
      • 自動氣道正壓通氣 (APAP) 裝置
    • 口腔矯正器
      • 下顎前移裝置
      • 舌頭固定裝置
      • 上顎快速擴張
      • 護齒套
    • 自適應伺服通氣 (ASV)
    • 氣道清理系統
    • 制氧裝置
    • 其他治療裝置

第 7 章：市場估計與預測：按最終用途，2021 - 2034 年

• 主要趨勢
• 居家照護機構及個人
• 睡眠實驗室和醫院

第 8 章：市場估計與預測：按地區分類，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 9 章：公司簡介

• Apple
• Asahi Kasei Corporation
• BMC Medical
• Cadwell Laboratories
• Drive DeVilbiss International
• Fisher & Paykel Healthcare
• Fitbit
• Koninklijke Philips NV
• LivaNova
• Natus Medical
• Nihon Kohden
• Oura Health
• ResMed
• Sleep Shepherd
• Sleepace
• Teleflex
• WEINMANN Emergency Medical Technology GmbH + Co. KG
• Withings
• Xiaomi

The Global Sleep Disorder Market, valued at USD 27.6 billion in 2024, is projected to grow at a robust CAGR of 10.1% from 2025 to 2034. This growth is primarily driven by the increasing prevalence of sleep disorders, the rising demand for advanced and portable treatment devices, and heightened awareness about sleep health.

The rising number of individuals affected by sleep disorders such as insomnia, sleep apnea, and narcolepsy is one of the key factors propelling the market. Modern lifestyles, characterized by higher stress levels, irregular sleep patterns, and excessive use of digital devices, have contributed significantly to the surge in sleep-related issues. As more people experience difficulties with sleep, the demand for a variety of treatments, including medications, therapeutic devices, and advanced diagnostic tools, has escalated.

Moreover, the growing understanding of the importance of sleep for overall health has amplified public awareness. Poor sleep has been linked to various chronic health issues, including cardiovascular disease, obesity, and mental health conditions, prompting more people to seek solutions. Health campaigns and educational initiatives are spreading the message about the importance of addressing sleep disorders, thus fueling demand for diagnostic services and treatment options, including therapies and devices.

The market is categorized by the type of disorder, with segments including sleep apnea, restless leg syndrome (RLS), insomnia, narcolepsy, and others. Sleep apnea is the largest contributor, accounting for a significant portion of the market. The disorder, particularly its obstructive form, is highly prevalent, especially among aging populations and individuals with other risk factors. As awareness surrounding sleep apnea continues to grow, the demand for both diagnostic and therapeutic solutions has surged, further cementing the market dominance of this segment.

The therapeutics segment is expected to drive significant growth, with a projected CAGR of 10.5%, reaching over USD 47.2 billion by 2034. Technological upgrades in therapeutic devices, especially for sleep apnea, have played a key role in this expansion. Devices like CPAP machines, which provide constant airflow to keep airways open, have been improved for better comfort and ease of use. The widespread adoption of insurance coverage for sleep disorder treatments has also made therapies more accessible, encouraging more individuals to seek treatment.

In terms of end use, the market is divided into home care settings and sleep laboratories. Home care settings, supported by the growing trend of self-management, dominate the market. Innovative home-based diagnostic and therapeutic devices, such as wearable sleep trackers and portable CPAP machines, have made it easier for individuals to monitor and treat sleep disorders from the comfort of their homes.

North America holds a significant share of the sleep disorder market, valued at USD 10.6 billion in 2024. The region's large population affected by sleep disorders, coupled with high access to specialized sleep care and advanced sleep technologies, is fueling market growth. Public awareness, insurance coverage, and the aging population further solidify North America's position in the global market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of sleep disorders
    • 3.2.1.2 Rising demand for portable, efficient, and superior devices for sleep disorders
    • 3.2.1.3 Increasing awareness regarding sleep disorders
    • 3.2.1.4 Technological advancements in sleep tech devices
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory framework
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Future market trends
• 3.6 Regulatory landscape
• 3.7 Reimbursement scenario
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Disorder Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Sleep apnea
  • 5.2.1 Obstructive sleep apnea
  • 5.2.2 Central sleep apnea/Complex sleep apnea
  • 5.2.3 Complex sleep apnea
• 5.3 Restless legs syndrome (RLS)
• 5.4 Insomnia
• 5.5 Narcolepsy
• 5.6 Other disorders

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Diagnostics
  • 6.2.1 Polysomnography (PSG) device
    • 6.2.1.1 Ambulatory PSG devices
    • 6.2.1.2 Clinical PSG devices
  • 6.2.2 Home sleep testing (HST) devices
    • 6.2.2.1 Type 2
    • 6.2.2.2 Type 3
    • 6.2.2.3 Type 4
  • 6.2.3 Actigraphy systems
  • 6.2.4 Sleep screening devices
  • 6.2.5 Pulse oximeter
  • 6.2.6 Respiratory polygraph
  • 6.2.7 Wearables
    • 6.2.7.1 Smart watches and bands
    • 6.2.7.2 Other wearables
• 6.3 Therapeutics
  • 6.3.1 Cognitive behavioral therapy
  • 6.3.2 Therapeutic devices
    • 6.3.2.1 Positive airway pressure (PAP) devices
      • 6.3.2.1.1 Continuous positive airway pressure (CPAP) devices
      • 6.3.2.1.2 Bilevel positive airway pressure (BiPAP) devices
      • 6.3.2.1.3 Automatic positive airway pressure (APAP) devices
    • 6.3.2.2 Oral appliances
      • 6.3.2.2.1 Mandibular advancement devices
      • 6.3.2.2.2 Tongue-retaining devices
      • 6.3.2.2.3 Rapid maxillary expansion
      • 6.3.2.2.4 Mouth guards
    • 6.3.2.3 Adaptive servo-ventilation (ASV)
    • 6.3.2.4 Airway clearance system
    • 6.3.2.5 Oxygen devices
    • 6.3.2.6 Other therapeutic devices

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Home care settings and individuals
• 7.3 Sleep laboratories and hospitals

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Apple
• 9.2 Asahi Kasei Corporation
• 9.3 BMC Medical
• 9.4 Cadwell Laboratories
• 9.5 Drive DeVilbiss International
• 9.6 Fisher & Paykel Healthcare
• 9.7 Fitbit
• 9.8 Koninklijke Philips N.V.
• 9.9 LivaNova
• 9.10 Natus Medical
• 9.11 Nihon Kohden
• 9.12 Oura Health
• 9.13 ResMed
• 9.14 Sleep Shepherd
• 9.15 Sleepace
• 9.16 Teleflex
• 9.17 WEINMANN Emergency Medical Technology GmbH + Co. KG
• 9.18 Withings
• 9.19 Xiaomi